p38 Kinase inhibitors for the treatment of arthritis and osteoporosis: thienyl, furyl, and pyrrolyl ureas

Add time:08/24/2019    Source:sciencedirect.com

Inhibitors of the MAP kinase p38 are potentially useful for the treatment for osteoporosis, arthritis, and other inflammatory diseases. A series of thienyl, furyl, and pyrrolyl ureas has been identified as potent p38 inhibitors, displaying in vitro activity in the nanomolar range.

We also recommend Trading Suppliers and Manufacturers of (2-ethylphenyl)urea (cas 114-32-9). Pls Click Website Link as below: cas 114-32-9 suppliers

Prev:Carbamates/Ureas
Next:Original articlePyridine-3-carboxamide-6-yl-ureas as novel inhibitors of bacterial DNA gyrase: Structure based design, synthesis, SAR and antimicrobial activity)